These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 34445799)

  • 1. Peptide-Assisted Nucleic Acid Delivery Systems on the Rise.
    Tarvirdipour S; Skowicki M; Schoenenberger CA; Palivan CG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology for delivery of peptide nucleic acids (PNAs).
    Gupta A; Bahal R; Gupta M; Glazer PM; Saltzman WM
    J Control Release; 2016 Oct; 240():302-311. PubMed ID: 26776051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharide-based nucleic acid nanoformulations.
    Raemdonck K; Martens TF; Braeckmans K; Demeester J; De Smedt SC
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1123-47. PubMed ID: 23680381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Peptide-Decorated Targeted Drug Delivery: Exploring Therapeutic Potential and Nanocarrier Strategies.
    Buddhiraju HS; Yadav DN; Dey S; Eswar K; Padmakumar A; Rengan AK
    ACS Appl Bio Mater; 2024 Aug; 7(8):4879-4893. PubMed ID: 37996391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptides, polypeptides and peptide-polymer hybrids as nucleic acid carriers.
    Ahmed M
    Biomater Sci; 2017 Oct; 5(11):2188-2211. PubMed ID: 28880322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in nanoparticulate systems for peptide, proteins and nucleic acid drug delivery.
    Slomkowski S; Gosecki M
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1823-39. PubMed ID: 21902630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonviral approach for targeted nucleic acid delivery.
    Jafari M; Soltani M; Naahidi S; Karunaratne DN; Chen P
    Curr Med Chem; 2012; 19(2):197-208. PubMed ID: 22320298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in peptide nucleic acid for cancer bionanotechnology.
    Wu JC; Meng QC; Ren HM; Wang HT; Wu J; Wang Q
    Acta Pharmacol Sin; 2017 Jun; 38(6):798-805. PubMed ID: 28414202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translatable High Drug Loading Drug Delivery Systems Based on Biocompatible Polymer Nanocarriers.
    Chen W; Zhou S; Ge L; Wu W; Jiang X
    Biomacromolecules; 2018 Jun; 19(6):1732-1745. PubMed ID: 29690764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier.
    Nafee N; Gouda N
    Curr Gene Ther; 2017; 17(2):154-169. PubMed ID: 28494740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
    Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
    Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic cycloamylose based nucleic acid nanocarriers.
    Prasher P; Sharma M; Agarwal V; Singh SK; Gupta G; Dureja H; Dua K
    Chem Biol Interact; 2024 May; 395():111000. PubMed ID: 38614318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.
    Yadav SC; Kumari A; Yadav R
    Peptides; 2011 Jan; 32(1):173-87. PubMed ID: 20934475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advancements in design of nucleic acid nanocarriers for controlled drug delivery.
    Mosley RJ; Rucci B; Byrne ME
    J Mater Chem B; 2023 Mar; 11(10):2078-2094. PubMed ID: 36806872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase supported design of carriers for therapeutic nucleic acid delivery.
    Krhac Levacic A; Morys S; Wagner E
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28963371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer.
    Liu Y; Xu CF; Iqbal S; Yang XZ; Wang J
    Adv Drug Deliv Rev; 2017 Jun; 115():98-114. PubMed ID: 28396204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.
    Castillo RR; Baeza A; Vallet-Regí M
    Biomater Sci; 2017 Feb; 5(3):353-377. PubMed ID: 28105473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into Targeted and Stimulus-Responsive Nanocarriers for Brain Cancer Treatment.
    Abousalman-Rezvani Z; Refaat A; Dehghankelishadi P; Roghani-Mamaqani H; Esser L; Voelcker NH
    Adv Healthc Mater; 2024 May; 13(12):e2302902. PubMed ID: 38199238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier.
    Avila YI; Chandler M; Cedrone E; Newton HS; Richardson M; Xu J; Clogston JD; Liptrott NJ; Afonin KA; Dobrovolskaia MA
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33513786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-Based Nanoassemblies in Gene Therapy and Diagnosis: Paving the Way for Clinical Application.
    Tarvirdipour S; Huang X; Mihali V; Schoenenberger CA; Palivan CG
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.